Pembrolizumab shows promising activity against head and neck cancer
Pembrolizumab shows promising activity against head and neck cancer
Prostate cancer and pharmacokinetics: Expert discussion
WIN 2015 hosts 'world class leaders' in personalised therapy
WIN 2015: Oncologists and industry working together for personalised medicine
Comment: Metastatic triple-negative breast cancer responds to immunotherapy
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer
PARP inhibitor combo shows early promise for patients with and without BRCA mutations
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer
Incidences of liver cancer rising in the USA
Black women found to have denser breast tissue than white women
New data shows that generic drivers are found in benign conditions